BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

Metabasis Therapeutics, Inc.  – Hepatitis B





 Company News
Dendreon Corporation (DNDN) Gets $296 Million Cash Bid From Deal-Hungry Valeant (VRX) for Provenge Assets as Bankruptcy Auction Looms 1/30/2015 5:58:13 AM
Valeant (VRX) Enters Super Bowl Frenzy With 30 Second $4.5 Million Toe Fungus Ad 1/29/2015 6:53:01 AM
Valeant (VRX) CEO Fesses Up to What Went Wrong in Pursuit of Allergan (AGN) 1/22/2015 6:41:15 AM
Valeant (VRX) Announces Redemption Of All Of The Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 1/16/2015 7:51:40 AM
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015 7:50:26 AM
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 1/15/2015 10:34:25 AM
J.P. Morgan: Valeant (VRX) Investors Should Expect "Small and Medium Sized" Deals in 2015, Says CFO 1/13/2015 10:09:07 AM
Valeant (VRX) To Present At The J.P. Morgan 2015 Healthcare Conference 1/6/2015 1:51:03 PM
Valeant (VRX) Possibly Eyeing Dental Device Makers Such as Align Technology, Inc. (ALGN) and DENTSPLY International Inc. (XRAY) in 2015: Analysts 12/31/2014 6:16:55 AM
Valeant (VRX) To Hold Conference Call To Announce 2015 Financial Guidance 12/16/2014 9:24:35 AM
12345678910...